Sunday, September 07, 2014

No down payment medical, dental and healthcare provider practice financing here! + More News: Germany's divisive road toll plan could make a loss - magazine + MORE 09/08/2014


Click Here For No Down Payment Medical Practice Financing for medical doctor practice start-ups and practice acquisitions!



Call: 904-551-6090




It is our deep understanding that you have very unique needs that are diverse from the rest the clients who want to have their own medical practice centers. We have set up systems in our company that will ensure that you get custom services that will meet your needs. Through this you will be able to attain the proper financial package. The attaining of the set company goals will hence be easy with the excellent medical practice loans start up company system.


Read The Interesting Snippets Below For Exciting Health-Care News!





Obama: U.S. must fight Ebola now or face long-term risk


– http://www.reuters.com/healthNews


WASHINGTON (Reuters) – The United States needs to do more to help control West Africa’s deadly Ebola outbreak to stop it becoming a global crisis that could one day threaten Americans, President Barack Obama said in an interview.

Continue Reading On http://www.reuters.com/healthNews »




Experimental Ebola vaccine protects monkeys for 10 months


– http://www.reuters.com/healthNews


NEW YORK (Reuters) – An experimental Ebola vaccine similar to one being developed by GlaxoSmithKline is effective for at least five weeks in lab monkeys but requires boosting with an additional vaccine to extend its protection to 10 months, according to a study published on Sunday.

Continue Reading On http://www.reuters.com/healthNews »




JERUSALEM (Reuters) – Shares of Israeli biotech firm Protalix reversed gains on Sunday after the company’s chief executive threw cold water on a news report that its technology could be used to develop a version of the Ebola experimental drug ZMapp.

Continue Reading On http://www.reuters.com/healthNews »




NEW YORK, Sept 7 (Reuters) – An experimental Ebola vaccine similar to one being developed by GlaxoSmithKline is effective for at least five weeks in lab monkeys but requires boosting with an additional vaccine to extend its protection to 10 months, according to a study published on Sunday.

Continue Reading On http://www.reuters.com »




* Minister says country in a better position now than weeks ago

Continue Reading On http://www.reuters.com »




* Bavarian CSU insist on introduction of new tolls on German roads

Continue Reading On http://www.reuters.com »




No down payment medical, dental and healthcare provider practice financing here! + More News: Germany's divisive road toll plan could make a loss - magazine + MORE 09/08/2014

No comments: